Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (repealed)
Print Options
PrintThe Whole
Directive
PrintThe Whole
Annex
PrintThe Whole
Division
PrintThis
Division
only
Changes over time for: Division X.
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Version Superseded: 01/09/2013
Status:
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
X.SUMMARY AND EVALUATION OF SECTIONS II TO IXU.K.
NotesU.K.
(1)These data must be submitted for the purified active substance of stated specification.U.K.
(2)These data must be submitted for the active substance of stated specification.U.K.
(3)Eye irritation test shall not be necessary where the active substance has been shown to have potential corrosive properties.U.K.
(4)The long-term toxicity and carcinogenicity of an active substance may not be required where a full justification demonstrates that these tests are not necessary.U.K.
(5)If, in exceptional circumstances, it is claimed that such testing is unnecessary, that claim must be fully justified.U.K.
Back to top